Clinical Trials Logo

Clinical Trial Summary

In parallel to the dramatic rise in metabolic diseases and diabetes observed over the past fifty years, the generalization of added sugar in processed food led to a marked increase in fructose consumption in almost all countries, and epidemiological studies demonstrated that the consumption of sugar-sweetened beverage (containing at least 50% of fructose) is associated with the development of diabetes, hepatic steatosis, dyslipidemia and obesity.

The objective of the study is to measure the amount of fructose that escape first-pass hepatic extraction after oral ingestion (fructose+glucose), and gain insights into its metabolic fates with the use of tracers.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03195062
Study type Interventional
Source University of Lausanne
Contact
Status Completed
Phase N/A
Start date March 23, 2017
Completion date August 31, 2018